Published in BMC Bioinformatics on April 25, 2005
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Mapping complex disease traits with global gene expression. Nat Rev Genet (2009) 7.44
Reliability and reproducibility issues in DNA microarray measurements. Trends Genet (2005) 6.79
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35
A gene expression bar code for microarray data. Nat Methods (2007) 4.20
Sequence biases in large scale gene expression profiling data. Nucleic Acids Res (2006) 3.83
Hybridization interactions between probesets in short oligo microarrays lead to spurious correlations. BMC Bioinformatics (2006) 3.44
Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med (2008) 3.31
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics (2006) 2.86
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer (2007) 2.40
Novel definition files for human GeneChips based on GeneAnnot. BMC Bioinformatics (2007) 2.32
Improved precision and accuracy for microarrays using updated probe set definitions. BMC Bioinformatics (2007) 2.17
Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics (2011) 2.09
Transcript-based redefinition of grouped oligonucleotide probe sets using AceView: high-resolution annotation for microarrays. BMC Bioinformatics (2007) 2.01
An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data. Genome Biol (2007) 1.83
Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol (2010) 1.73
Consistent annotation of gene expression arrays. BMC Genomics (2010) 1.62
Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One (2009) 1.55
Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol (2006) 1.53
GATExplorer: genomic and transcriptomic explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs. BMC Bioinformatics (2010) 1.52
Empirical comparison of cross-platform normalization methods for gene expression data. BMC Bioinformatics (2011) 1.35
Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes. Bioinformatics (2009) 1.29
Three methods for optimization of cross-laboratory and cross-platform microarray expression data. Nucleic Acids Res (2007) 1.21
Comparison of three microarray probe annotation pipelines: differences in strategies and their effect on downstream analysis. BMC Proc (2009) 1.19
Review of the literature examining the correlation among DNA microarray technologies. Environ Mol Mutagen (2007) 1.14
The end of the microarray Tower of Babel: will universal standards lead the way? J Biomol Tech (2006) 1.11
Comparison of the latest commercial short and long oligonucleotide microarray technologies. BMC Genomics (2006) 1.11
Measuring global gene expression in polyploidy; a cautionary note from allohexaploid wheat. Funct Integr Genomics (2007) 1.01
Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol (2010) 0.99
Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family. BMC Med Genomics (2009) 0.97
Physiology, pathology and relatedness of human tissues from gene expression meta-analysis. PLoS One (2008) 0.97
An analysis of intra array repeats: the good, the bad and the non informative. BMC Genomics (2006) 0.95
A detailed transcript-level probe annotation reveals alternative splicing based microarray platform differences. BMC Genomics (2007) 0.95
Expectations, validity, and reality in gene expression profiling. J Clin Epidemiol (2010) 0.93
Salvaging Affymetrix probes after probe-level re-annotation. BMC Res Notes (2008) 0.92
Comparison and consolidation of microarray data sets of human tissue expression. BMC Genomics (2010) 0.91
Cross-platform expression microarray performance in a mouse model of mitochondrial disease therapy. Mol Genet Metab (2009) 0.91
Probe mapping across multiple microarray platforms. Brief Bioinform (2011) 0.89
Exon-based mapping of microarray probes: recovering differential gene expression signal in underpowered hypoxia experiment. Mol Cell Probes (2006) 0.89
Identical probes on different high-density oligonucleotide microarrays can produce different measurements of gene expression. BMC Genomics (2006) 0.89
Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci (2008) 0.88
On the necessity of different statistical treatment for Illumina BeadChip and Affymetrix GeneChip data and its significance for biological interpretation. Biol Direct (2008) 0.87
Integrative computational biology for cancer research. Hum Genet (2011) 0.85
Comparison of gene expression profile in embryonic mesencephalon and neuronal primary cultures. PLoS One (2009) 0.84
The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism. BMC Genomics (2008) 0.84
FDA perspectives on potential microarray-based clinical diagnostics. Hum Genomics (2006) 0.84
Development and evaluation of new mask protocols for gene expression profiling in humans and chimpanzees. BMC Bioinformatics (2009) 0.82
Application of a correlation correction factor in a microarray cross-platform reproducibility study. BMC Bioinformatics (2007) 0.81
Analysis of probe level patterns in Affymetrix microarray data. BMC Bioinformatics (2007) 0.81
Comparative analysis of acute and chronic corticosteroid pharmacogenomic effects in rat liver: transcriptional dynamics and regulatory structures. BMC Bioinformatics (2010) 0.79
Microarray probes and probe sets. Front Biosci (Elite Ed) (2010) 0.79
Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome. J Ovarian Res (2015) 0.75
Correction of spatial bias in oligonucleotide array data. Adv Bioinformatics (2013) 0.75
ArrayInitiative - a tool that simplifies creating custom Affymetrix CDFs. BMC Bioinformatics (2011) 0.75
Structured oligonucleotides for target indexing to allow single-vessel PCR amplification and solid support microarray hybridization. Analyst (2015) 0.75
Meta-Analysis of Gene Expression Profiles in Acute Promyelocytic Leukemia Reveals Involved Pathways. Int J Hematol Oncol Stem Cell Res (2017) 0.75
Cross-platform Comparison of Two Pancreatic Cancer Phenotypes. Cancer Inform (2010) 0.75
Microarray Я US: a user-friendly graphical interface to Bioconductor tools that enables accurate microarray data analysis and expedites comprehensive functional analysis of microarray results. BMC Res Notes (2012) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
dbEST--database for "expressed sequence tags". Nat Genet (1993) 41.10
Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A (2001) 17.36
A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31
Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30
Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res (2003) 8.08
Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A (2001) 7.51
Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07
Gene expression predictors of breast cancer outcomes. Lancet (2003) 6.99
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med (2004) 6.91
Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res (2002) 6.70
Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. Nucleic Acids Res (2004) 4.43
Alternative mapping of probes to genes for Affymetrix chips. BMC Bioinformatics (2004) 3.56
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest (2002) 3.36
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol (2003) 2.52
Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics (2003) 2.20
Technology for microarray analysis of gene expression. Curr Opin Biotechnol (1998) 1.58
A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics (2004) 1.28
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol (2006) 30.90
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A (2005) 8.75
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat (2009) 7.91
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet (2006) 7.16
Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07
Reliability and reproducibility issues in DNA microarray measurements. Trends Genet (2005) 6.79
Robustness of cellular functions. Cell (2004) 6.65
The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. J Am Med Inform Assoc (2009) 6.49
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Creation and implications of a phenome-genome network. Nat Biotechnol (2006) 5.79
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol (2010) 5.50
Tectonic shifts in the health information economy. N Engl J Med (2008) 5.42
Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. Nucleic Acids Res (2004) 4.43
Cluster analysis of gene expression dynamics. Proc Natl Acad Sci U S A (2002) 3.83
Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A (2007) 3.72
Chromosomal instability confers intrinsic multidrug resistance. Cancer Res (2011) 3.70
A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A (2008) 3.57
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48
MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics (2005) 3.23
Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A (2007) 3.03
No small change for the health information economy. N Engl J Med (2009) 2.92
Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks. BMC Bioinformatics (2005) 2.83
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med (2010) 2.62
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60
Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet (2007) 2.54
The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS One (2007) 2.52
Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics (2004) 2.51
The SMART Platform: early experience enabling substitutable applications for electronic health records. J Am Med Inform Assoc (2012) 2.48
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature (2013) 2.46
The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet (2005) 2.46
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci Transl Med (2013) 2.34
Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J (2003) 2.30
A submission model for use in the indexing, searching, and retrieval of distributed pathology case and tissue specimens. Stud Health Technol Inform (2004) 2.28
Minimal haplotype tagging. Proc Natl Acad Sci U S A (2003) 2.28
Reproducibility of gene expression across generations of Affymetrix microarrays. BMC Bioinformatics (2003) 2.20
Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records. J Am Med Inform Assoc (2009) 2.20
GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A (2008) 2.17
Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev (2004) 2.16
Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A (2009) 2.12
Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells. PLoS One (2008) 2.10
Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics (2011) 2.09
Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell (2009) 2.09
Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res (2011) 2.05
The PING personally controlled electronic medical record system: technical architecture. J Am Med Inform Assoc (2004) 2.01
Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care (2009) 2.00
Escaping the EHR trap--the future of health IT. N Engl J Med (2012) 1.96
Technical desiderata for the integration of genomic data into Electronic Health Records. J Biomed Inform (2011) 1.96
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Finding the missing link for big biomedical data. JAMA (2014) 1.90
A self-scaling, distributed information architecture for public health, research, and clinical care. J Am Med Inform Assoc (2007) 1.88
Transcriptomic analysis of human lung development. Am J Respir Crit Care Med (2009) 1.87
SHRINE: enabling nationally scalable multi-site disease studies. PLoS One (2013) 1.80
The MAPPER database: a multi-genome catalog of putative transcription factor binding sites. Nucleic Acids Res (2005) 1.80
Does collocation inform the impact of collaboration? PLoS One (2010) 1.78
Increased measurement accuracy for sequence-verified microarray probes. Physiol Genomics (2004) 1.75
The asthma kiosk: a patient-centered technology for collaborative decision support in the emergency department. J Am Med Inform Assoc (2004) 1.70
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med (2012) 1.70
Parents as partners in obtaining the medication history. J Am Med Inform Assoc (2005) 1.67
Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samples. PLoS One (2011) 1.62
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials (2014) 1.62
A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics Network. Hum Pathol (2007) 1.59
Effect of acute aldosterone administration on gene expression profile in the heart. Endocrinology (2006) 1.58
Antidepressant response in patients with major depression exposed to NSAIDs: a pharmacovigilance study. Am J Psychiatry (2012) 1.57
Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One (2009) 1.55
Training the next generation of informaticians: the impact of "BISTI" and bioinformatics--a report from the American College of Medical Informatics. J Am Med Inform Assoc (2004) 1.53
Bayesian approach to discovering pathogenic SNPs in conserved protein domains. Hum Mutat (2004) 1.51
Inter-species differences of co-expression of neighboring genes in eukaryotic genomes. BMC Genomics (2004) 1.50
Replacing cRNA targets with cDNA reduces microarray cross-hybridization. Nat Biotechnol (2006) 1.49
Toward more transparent and reproducible omics studies through a common metadata checklist and data publications. OMICS (2014) 1.49
Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells (2006) 1.46
Identification of patients with diabetes from the text of physician notes in the electronic medical record. Diabetes Care (2005) 1.44
Linking gene expression data with patient survival times using partial least squares. Bioinformatics (2002) 1.42
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. Cancer Immunol Immunother (2014) 1.42
Identification of a transcriptional profile associated with in vitro invasion in non-small cell lung cancer cell lines. Cancer Biol Ther (2004) 1.42
Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin. J Cell Biol (2006) 1.42
Parallel evolution of tumour subclones mimics diversity between tumours. J Pathol (2013) 1.42
QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ (2013) 1.40
Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.38
An epidemiological network model for disease outbreak detection. PLoS Med (2007) 1.31
A SNP-centric database for the investigation of the human genome. BMC Bioinformatics (2004) 1.31
A glimpse of the next 100 years in medicine. N Engl J Med (2012) 1.30
Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc Natl Acad Sci U S A (2003) 1.29
A variable fold change threshold determines significance for expression microarrays. FASEB J (2002) 1.27